Physician profile
Robert B Clark
NPI 1689692071
$430.70
in general payments reported to CMS, 2019-2025
12 companies · $16.55 in 2025
The $16.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $125 · 2021: $43.56 · 2022: $13.55 · 2025: $16.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $105.39 | 2019-2022 | |
| Amgen INC. | $71.40 | 2019-2025 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.22 | 2019-2020 | |
| Allergan, INC. | $35.45 | 2019-2020 | |
| Lilly USA, LLC | $30.87 | 2020-2021 | |
| Abbvie INC. | $29.75 | 2021 | |
| Merck Sharp & Dohme LLC | $27.56 | 2019-2020 | |
| Cranial Technologies, INC | $23.71 | 2020 | |
| Sanofi Pasteur INC. | $18.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.07 | 2020 | |
| Alfasigma USA, INC. | $14.83 | 2020 | |
| Amarin Pharma, INC. | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.